Summary
The renowned **Hong Thai** herbal inhaler brand is facing a significant crisis after announcing the recall of **200,000 contaminated units**. The recall follows a failed microbial contamination test by the **Thai Food and Drug Administration (FDA)** on a batch manufactured in December 2024. Simultaneously, consumer protection police and FDA officials raided **four unauthorized production sites** in Bangkok and Samut Sakhon, seizing over **2.35 million herbal products** valued at more than **100 million baht** ($3.1 million). The company owner, **Theerapong Rabuetham**, has pledged full responsibility, while facing potential legal action for both product contamination and unlicensed manufacturing.
Key Takeaways
- Hong Thai is recalling 200,000 inhalers due to microbial contamination.
- Authorities raided three illegal production sites, seizing over 2.35 million products.
- The company owner has pledged full responsibility and plans to build a new facility.
- The FDA is considering legal action against Hong Thai for product and manufacturing violations.
- The incident highlights regulatory challenges in Thailand's herbal product industry.
Balanced Perspective
The **Thai FDA** has confirmed that a specific lot of **Hong Thai Brand Herbal Inhaler Formula 2** (registration number G 308/62, lot 332) failed microbial contamination testing. The company is cooperating with the FDA to understand the extent of the contamination and its cause. Concurrently, authorities have uncovered and raided **three unlicensed production facilities** operating in addition to the company's authorized site, leading to the seizure of a substantial quantity of products. Legal proceedings are anticipated for both the product defect and the illegal manufacturing operations.
Optimistic View
This crisis, while serious, presents an opportunity for **Hong Thai** to emerge stronger. The owner's immediate pledge of **100% responsibility** and commitment to destroying recalled products signals a genuine intent to rectify the situation. The planned investment in a **new manufacturing facility** with upgraded machinery and stricter quality control, coupled with transparent communication with the FDA, could rebuild consumer trust and set a new industry standard for safety and compliance. This could ultimately enhance the brand's international reputation for quality.
Critical View
The discovery of microbial contamination and the simultaneous raid on multiple illegal factories paint a grim picture for **Hong Thai**. The sheer scale of the unauthorized production – **three extra sites** and over **2.35 million seized products** – suggests a systemic disregard for regulations, potentially driven by profit over safety. This dual failure not only jeopardizes consumer health but also severely damages the brand's international credibility, which has been built on celebrity endorsements and use by athletes. The legal penalties and potential loss of trust could be insurmountable.
Source
Originally reported by Khaosod English